Citation: Ho. Yang et al., BIOLOGICAL AND PHARMACOLOGICAL EFFECTS OF PINUSOLIDE, A NOVEL PLATELET-ACTIVATING-FACTOR ANTAGONIST, Planta medica, 61(6), 1995, pp. 519-522
Citation: Ho. Yang et al., ISOLATION AND CHARACTERIZATION OF PLATELET-ACTIVATING-FACTOR RECEPTOR-BINDING ANTAGONISTS FROM BIOTA-ORIENTALIS, Planta medica, 61(1), 1995, pp. 37-40
Citation: Dy. Suh et al., METABOLIC-FATE OF THE NEW ANTITHROMBOTIC AGENT ASPALATONE IN RATS - IN-VIVO AND IN-VITRO STUDY, Arzneimittel-Forschung, 45-2(10), 1995, pp. 1071-1074
Citation: Ds. Kim et al., EVIDENCE FOR SELECTION OF 11 AMINO-ACID CDR3 DOMAINS IN HUMKV325-DERIVED IMMUNOGLOBULIN LIGHT-CHAINS IN KAWASAKI-DISEASE, Arthritis and rheumatism, 38(9), 1995, pp. 1096-1096
Citation: Sh. Pyo et Bh. Han, ACTIVATED MOLYBDENUM PROMOTED REDUCTION OF NITROARENES WITH HYDRAZINEMONOHYDRATE, Bulletin of the Korean Chemical Society, 15(11), 1994, pp. 1012-1013
Authors:
HAN BH
SUH DY
YANG HO
PARK YH
KANG YH
KIM YC
Citation: Bh. Han et al., SYNTHESIS AND ANTIPLATELET EFFECTS OF THE NEW ANTITHROMBOTIC AGENT ASPALATONE WITH LOW ULCEROGENICITY, Arzneimittel-Forschung, 44-2(10), 1994, pp. 1122-1126
Authors:
HAN BH
SUH DY
YANG HO
PARK YH
KANG YH
KIM YC
Citation: Bh. Han et al., SYNTHESIS AND ANTIPLATELET EFFECTS OF THE NEW ANTITHROMBOTIC AGENT ASPALATONE WITH LOW ULCEROGENICITY, Arzneimittel-Forschung, 44-2(10), 1994, pp. 1122-1126
Authors:
BECKER LB
HAN BH
MEYER PM
WRIGHT FA
RHODES KV
SMITH DW
BARRETT J
Citation: Lb. Becker et al., RACIAL-DIFFERENCES IN THE INCIDENCE OF CARDIAC-ARREST AND SUBSEQUENT SURVIVAL, The New England journal of medicine, 329(9), 1993, pp. 600-606